Singapore markets close in 9 minutes
Straits Times Index
3,309.68 -3.80 (-0.11%) Nikkei
39,069.68 +282.30 (+0.73%) Hang Seng
19,636.22 +82.61 (+0.42%) FTSE 100
8,441.20 +20.94 (+0.25%) Bitcoin USD
66,798.27 -393.18 (-0.59%) CMC Crypto 200
1,365.56 +11.14 (+0.82%)
NVAX Jan 2025 7.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:22PM EDT. Market open.
| Previous close | 0.9500 |
| Open | 1.1300 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 7.50 |
| Expiry date | 2025-01-17 |
| Day's range | 0.9500 - 1.2100 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksThe Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers are included in this Analyst Blog.
ZacksBiotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
FX EmpireNovavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
The past five days have been a rollercoaster for Novavax investors, as the share price of the company skyrocketed by over 200% following the announcement of a major deal with French pharmaceutical giant Sanofi.
© 2024 Yahoo. All rights reserved.